Plasma level of stromal derived factor-1 (SDF-1) is increased in disseminated intravascular coagulation patients who have poor outcomes: In vitro effect of SDF-1 on coagulopathy

Thrombosis Research

Volumn 120, Issue 4, 2007, Pages 559-566

  Kyung Kim, Hyun ^a   Kim, Ji Eun ^a   Chung, Junho ^a   Soon Lee, Dong ^a   Han, Kyou Sup ^a   Park, Seonyang ^a   Cho, Han Ik ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Disseminated intravascular coagulation; Platelet; Stromal derived factor 1; Thrombomodulin; Tissue factor

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; THROMBOCYTE ACTIVATING FACTOR; THROMBOMODULIN; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTIC LEUKEMIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE FUNCTION;

CELLS, CULTURED; CHEMOKINES, CXC; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIAL CELLS; HUMANS; MONOCYTES; PLATELET FUNCTION TESTS; PROGNOSIS; THROMBOMODULIN; THROMBOPHILIA; THROMBOPLASTIN;

EID: 34447645988     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.11.011     Document Type: Article

References (37)

1. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 938 (2001) 83-95
2. Ponomaryov T., Peled A., Petit I., Taichman R.S., Habler L., Sandbank J., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106 (2000) 1331-1339
3. Mizuno K., Matsuyama W., Mitsuyama H., Watanabe M., Higashimoto I., Osame M., et al. Clinical investigation: increased serum stromal derived factor 1 alpha levels in pulmonary tuberculosis. Clin Exp Immunol 139 (2005) 490-497
4. Shirozu M., Nakano T., Inazawa J., Tashiro K., Tada H., Shinohara T., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28 (1995) 495-500
5. Hamada T., Mohle R., Hesselgesser J., Hoxie J., Nachman R.L., Moore M.A., et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 188 (1998) 539-548
6. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., and Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 269 (1994) 232-237
7. Kowalska M.A., Ratajczak J., Hoxie J., Brass L.F., Gewirtz A., Poncz M., et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 104 (1999) 220-229
8. Gonzalo J.A., Lloyd C.M., Peled A., Delaney T., Coyle A.J., and Gutierrez-Ramos J.C. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 165 (2000) 499-508
9. Villalba S., Salvucci O., Aoki Y., De La Luz Sierra M., Gupta G., Davis D., et al. Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo. J Leukoc Biol 74 (2003) 880-888
10. Egorina E.M., Sovershaev M.A., Bjorkoy G., Gruber F.X., Olsen J.O., Parhami-Seren B., et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 25 (2005) 1493-1498
11. Engstad C.S., Lia K., Rekdal O., Olsen J.O., and Osterud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 58 (1995) 575-581
12. Oeth P., Parry G.C., and Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 17 (1997) 365-374
13. Van de Wouwer M., Collen D., and Conway E.M. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24 (2004) 1374-1383
14. Sohn R.H., Deming C.B., Johns D.C., Champion H.C., Bian C., Gardner K., et al. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105 (2005) 3910-3917
15. Levi M. Disseminated intravascular coagulation: what's new?. Crit Care Clin 21 (2005) 449-467
16. Osterud B., and Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 27 (2001) 605-617
17. Moore K.L., Andreoli S.P., Esmon N.L., Esmon C.T., and Bang N.U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79 (1987) 124-130
18. Yahara Y., Okawa S., Onozawa Y., Motomiya T., Tanoue K., and Yamazaki H. Activation of platelets in cancer, especially with reference to genesis of disseminated intravascular coagulation. Thromb Res 29 (1983) 27-35
19. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
20. Napoleone E., Di Santo A., and Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 89 (1997) 541-549
21. Bick R.L. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 8 (2002) 1-31
22. Shalekoff S., and Tiemessen C.T. Circulating levels of stromal cell-derived factor 1alpha and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes. AIDS Res Hum Retroviruses 19 (2003) 461-468
23. Mittal G.A., Joshi V.R., and Deshpande A. Stromal cell-derived factor-1 alpha in rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 915-916
24. Katsuta T., Lim C., Shimoda K., Shibuta K., Mitra P., Banner B.F., et al. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am J Gastroenterol 95 (2000) 3157-3164
25. Balabanian K., Couderc J., Bouchet-Delbos L., Amara A., Berrebi D., Foussat A., et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 170 (2003) 3392-3400
26. Levi M., de Jonge E., and Meijers J. The diagnosis of disseminated intravascular coagulation. Blood Rev 16 (2002) 217-223
27. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39 (2003) 184-191
28. Baj-Krzyworzeka M., Majka M., Pratico D., Ratajczak J., Vilaire G., Kijowski J., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30 (2002) 450-459
29. Drake T.A., Morrissey J.H., and Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134 (1989) 1087-1097
30. Osterud B., and Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 49 (1983) 5-7
31. Esmon C.T. The protein C anticoagulant pathway. Arterioscler Thromb 12 (1992) 135-145
32. Nawroth P.P., and Stern D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163 (1986) 740-745
33. Salvucci O., Yao L., Villalba S., Sajewicz A., Pittaluga S., and Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99 (2002) 2703-2711
34. Gear A.R., Suttitanamongkol S., Viisoreanu D., Polanowska-Grabowska R.K., Raha S., and Camerini D. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97 (2001) 937-945
35. Shenkman B., Brill A., Brill G., Lider O., Savion N., and Varon D. Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alpha. J Thromb Haemost 2 (2004) 154-160
36. Abi-Younes S., Sauty A., Mach F., Sukhova G.K., Libby P., and Luster A.D. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86 (2000) 131-138
37. Gear A.R., and Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10 (2003) 335-350